"We are excited about the many opportunities for sales growth and new products that we anticipate as a result of this strategic acquisition," said Catherine M. Burzik, president of Applied Biosystems.
"We welcome Ambion's employees and anticipate a smooth integration of product lines and personnel as we accelerate the delivery of more complete workflow solutions to our global customer base."
The research and development, manufacturing, and other operations of Ambions Research Products Division will continue to be based in Austin, Texas and its approximately 300 employees will be integrated into the Applied Biosystems global workforce of approximately 4,000 employees.
Ambion will become a center of excellence within the Molecular Biology Divisions consumables business with a focus on expanding the range of consumables products in the Applied Biosystems portfolio.
Recent Ambion product introductions include reagents associated with microRNA and RNA interference.